Tag: pharmaceuticals native starch market share

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Pharmaceuticals Native Starch Market Forecast: What Value Will The Market Reach By 2030?#_x000D_

The pharmaceuticals native starch market size has shown significant growth in recent years. This market is expected to expand from $6.11 billion in 2025 to $6.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. The historical growth of this market stemmed from factors including the accessibility of natural starch sources, the rise of generic pharmaceuticals, the widespread application in tablets and capsules, cost sensitivity in drug manufacturing, and the regulatory acceptance of native starch._x000D_

_x000D_

The pharmaceuticals native starch market is predicted to experience significant expansion over the next few years. It is expected to grow to $9.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period is driven by an increase in clean-label drug formulations, stricter sustainability requirements, the expansion of pharmaceutical manufacturing into emerging markets, a rising demand for biodegradable excipients, and advancements in starch processing. Major trends anticipated during this period include a growing demand for natural and clean-label excipients, increasing utilization in solid oral dosage forms, greater adoption as a binder and disintegrant, the expansion of plant-based pharmaceutical ingredients, and an increasing focus on cost-effective excipients._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=67338368&type=smp&name=Pharmaceuticals%20Native%20Starch%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Pharmaceuticals Native Starch Market Growth Factors Behind Sustained Expansion#_x000D_

The increasing prevalence of chronic diseases is anticipated to propel the growth of the pharmaceuticals native starch market moving forward. Chronic conditions are long-term medical issues that typically progress slowly and last for a year or more. The rising incidence of chronic diseases is primarily attributed to an aging population, as older individuals are more susceptible to long-term health problems such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with advancing age. Pharmaceuticals native starch is beneficial for chronic diseases by enhancing drug formulation stability, improving bioavailability, enabling controlled drug release, supporting patient adherence, and ultimately strengthening the effectiveness and long-term management of chronic medical conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 76.4% of U.S. adults, representing approximately 194 million people, reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the growing prevalence of chronic diseases is driving the expansion of the pharmaceuticals native starch market. The expansion of generic drug manufacturing is expected to propel the growth of the pharmaceuticals native starch market in the future. Generic drug manufacturing refers to the production of off-patent medications that are bioequivalent to branded drugs. Generic drug manufacturing is on the rise due to increasing regulatory support that accelerates approvals and encourages more companies to produce affordable alternatives to branded medicines. The growth of generic drug manufacturing supports pharmaceuticals native starch by increasing the need for reliable, cost-effective excipients that enhance tablet formulation, stability, and drug delivery efficiency across a broader range of high-volume generic medicines. For instance, in November 2024, according to the Food and Drug Administration (FDA), a US-based federal agency, in FY 2023, the FDA approved 782 Abbreviated New Drug Applications (ANDAs), an increase from 722 approvals recorded in FY 2022. Therefore, the expansion of generic drug manufacturing is driving the growth of the pharmaceuticals native starch market._x000D_

_x000D_

#Pharmaceuticals Native Starch Market Segments: Where Is Growth Concentrated?#_x000D_

The pharmaceuticals native starch market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Potato Starch, Corn Starch, Other Types_x000D_

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations_x000D_

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent_x000D_

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents_x000D_

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users_x000D_

_x000D_

Subsegments:_x000D_

1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch_x000D_

2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch_x000D_

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch_x000D_

_x000D_

#Pharmaceuticals Native Starch Market Industry Trends Fueling Future Revenue Growth#_x000D_

Leading companies in the pharmaceuticals native starch market are focusing on developing innovative products, such as plant-based textures, to enhance drug formulation and improve patient compliance. Plant-based texture refers to the physical properties derived from plant ingredients, such as thickness and gel strength, and helps pharmaceuticals utilize native starch by improving tablet binding, disintegration, and mouthfeel for enhanced natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer aimed at improving texture and stability in dairy and alternative dairy products. This innovative pharmaceutical native starch offers functional properties that enhance drug formulation performance, bioavailability, and controlled release while supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch is a versatile ingredient that improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, using clean-label, natural ingredients._x000D_

_x000D_

#Pharmaceuticals Native Starch Market Key Participants And Competitive Landscape#_x000D_

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd. _x000D_

_x000D_

#View The Full Pharmaceuticals Native Starch Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Pharmaceuticals Native Starch Market Global Footprint: Which Region Leads The Market?#_x000D_

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Pharmaceuticals Native Starch Market Size And Revenue Forecast Through 2030

The market for native starch in pharmaceuticals has experienced significant expansion in recent years, with its value climbing from $6.11 billion in 2025 to $6.64 billion in 2026—a compound annual growth rate (CAGR) of 8.6%. Several factors have driven this growth in the historical period: the ready availability of natural starch sources, the broadening scope of generic pharmaceuticals, the prevalent utilization of tablets and capsules, cost considerations in drug formulation, and the regulatory endorsement of native starch.

The pharmaceuticals native starch market is projected to experience robust expansion over the coming years, reaching a valuation of $9.23 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period is fueled by several key factors, including the rise of clean-label drug formulations, heightened sustainability demands, the broadening of pharmaceutical production in emerging economies, a growing preference for biodegradable excipients, and ongoing improvements in starch processing technologies. Among the prominent trends shaping this period are the escalating demand for natural and clean-label excipients, their increased application in solid oral dosage forms, wider adoption as binders and disintegrants, the expansion of plant-based pharmaceutical ingredients, and a stronger emphasis on cost-effective excipient solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmaceuticals Native Starch Market Industry Drivers: What Is Driving Revenue Growth?

The rising incidence of chronic illnesses is anticipated to drive forward the expansion of the pharmaceuticals native starch market. Chronic diseases are long-term medical conditions that develop gradually and endure for at least a year. This increase is largely due to the growing elderly population, as older individuals face a higher risk of conditions such as diabetes, cardiovascular ailments, arthritis, and cancer, all of which become more common with advancing age. Native starch in pharmaceuticals benefits chronic disease management by improving drug formulation stability, enhancing bioavailability, facilitating controlled drug release, promoting patient adherence, and thereby boosting both the effectiveness and sustained treatment of chronic health issues. For example, in April 2025, data from the Centers for Disease Control and Prevention, a U.S. federal public health organization, indicated that 76.4% of American adults, around 194 million people, reported having at least one chronic condition in 2023, with prevalence rates of 59.5% among young adults, 78.4% among middle-aged adults, and 93.0% among older adults. Consequently, the growing prevalence of chronic diseases is fueling the rise of the pharmaceuticals native starch market.

The growth of the pharmaceuticals native starch market is set to be driven by the expansion of generic drug manufacturing. This process involves producing off-patent medications that are bioequivalent to their branded counterparts. The rise in generic drug manufacturing stems from enhanced regulatory support that accelerates approvals and enables more companies to develop affordable substitutes for branded drugs. This expansion supports pharmaceuticals native starch by boosting demand for dependable, economical excipients that improve tablet formulation, stability, and drug delivery efficiency across a wide array of high-volume generic medications. In November 2024, the U.S.-based Food and Drug Administration (FDA) reported that 782 Abbreviated New Drug Applications (ANDAs) were approved in FY 2023, marking an increase from 722 in FY 2022. Thus, the growth of generic drug manufacturing is propelling the pharmaceuticals native starch market forward.

Pharmaceuticals Native Starch Market Segment Landscape: Which Areas Lead Market Development?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch

2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Pharmaceuticals Native Starch Market Growth Trends: What Is Influencing The Future Outlook?

Key players in the pharmaceuticals native starch market are concentrating their efforts on creating innovative products—for example, textures derived from botanical sources—to improve medication composition and boost patient adherence to treatment. Such textures are defined by physical attributes obtained from plant ingredients, including thickness and gel strength, and they assist pharmaceutical applications of native starch by improving tablet binding, disintegration, and mouthfeel, thereby facilitating better natural drug formulations. As an example, in February 2024, Ingredion Incorporated, a U.S.-based food firm, introduced Novation Indulge 2940 starch, a clean-label texturizing agent designed to enhance texture and stability in dairy and alternative dairy items. This innovative pharmaceutical native starch provides functional characteristics that boost the performance of drug formulations, drug absorption, and sustained release, while simultaneously facilitating the creation of clean-label, sustainable products. NOVATION Indulge 2940 starch is a multipurpose component that enhances texture, stability, and consumer appeal in both dairy and alternative dairy products, by employing plant-derived, clean-label components.

Pharmaceuticals Native Starch Market Industry Leaders And Market Competition

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

Access The Complete Pharmaceuticals Native Starch Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Pharmaceuticals Native Starch Market Regional Outlook: Where Are The Largest Opportunities Located?

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Pharmaceuticals Native Starch Market During 2026–2030?

The pharmaceuticals native starch market size has seen strong expansion in recent years. It is anticipated to increase from $6.11 billion in 2025 to $6.64 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.6%. The historical growth in this market can be linked to the accessibility of natural starch sources, the proliferation of generic pharmaceuticals, the widespread adoption of tablets and capsules, the emphasis on cost sensitivity in drug formulation, and the regulatory acceptance of native starch.

The pharmaceuticals native starch market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $9.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth during the forecast period include the rise in clean-label drug formulations, stricter sustainability requirements, the expansion of pharmaceutical production facilities in developing regions, an increasing need for biodegradable excipients, and ongoing advancements in starch processing techniques. Key trends anticipated for this period encompass a surging demand for natural and clean-label excipients, their expanded application in solid oral dosage forms, their increasing role as binders and disintegrants, the broader development of plant-based pharmaceutical components, and a heightened emphasis on economically viable excipients.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Drivers Are Advancing The Pharmaceuticals Native Starch Market Growth?

The rising occurrence of chronic illnesses is anticipated to fuel the expansion of the pharmaceuticals native starch market. These are enduring health issues that typically advance gradually and persist for at least a year. The growing incidence of chronic conditions is primarily linked to an expanding aging demographic, as older individuals are more prone to conditions such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with advancing age. Pharmaceuticals native starch contributes to managing chronic diseases by enhancing drug formulation stability, boosting bioavailability, facilitating controlled drug delivery, aiding patient adherence, and ultimately improving the efficacy and long-term management of these conditions. For example, the Centers for Disease Control and Prevention, a US federal public health agency, reported in April 2025 that 76.4% of U.S. adults, amounting to approximately 194 million people, had one or more chronic conditions in 2023. This prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the increasing prevalence of chronic diseases is a key factor driving the pharmaceuticals native starch market’s growth. The growth in generic drug production is anticipated to boost the pharmaceuticals native starch market in the coming years. Generic drug manufacturing involves creating off-patent medications that possess the same bioequivalence as their branded counterparts. This rise in generic drug manufacturing is fueled by increased regulatory backing, which accelerates approval processes and motivates more companies to develop economical alternatives to proprietary drugs. The broadening of generic drug production aids pharmaceuticals native starch by heightening the need for dependable, economical excipients that improve tablet formulation, stability, and the effectiveness of drug delivery across a wider array of high-volume generic medications. For example, the Food and Drug Administration (FDA), a US federal agency, reported in November 2024 that it approved 782 Abbreviated New Drug Applications (ANDAs) in fiscal year 2023, an increase from 722 approvals in fiscal year 2022. Consequently, the expansion of generic drug manufacturing is a significant driver for the pharmaceuticals native starch market.

How Is Segment Classification Applied In The Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch

2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

What Trends Are Impacting The Pharmaceuticals Native Starch Market?

Major companies in the pharmaceuticals native starch market are concentrating on developing innovative products, such as plant-derived textures, to enhance drug formulation and improve patient adherence. Plant-based texture refers to the physical characteristics derived from plant ingredients, including thickness and gel strength, assisting pharmaceuticals in using native starch by improving tablet binding, disintegration, and mouthfeel for enhanced natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to enhance texture and stability in dairy and alternative dairy products. This innovative pharmaceutical native starch offers functional properties that boost drug formulation performance, bioavailability, and controlled release while supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch is a versatile ingredient that improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, using clean-label, natural ingredients.

Which Key Players Are Active In The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

Access The Complete Pharmaceuticals Native Starch Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

Which Regional Market Leads The Pharmaceuticals Native Starch Market?

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharmaceuticals Native Starch Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2026, By The Business Research Company

Modified Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/modified-starch-global-market-report

Industrial Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-starch-global-market-report

Starch Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/starch-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Pharmaceuticals Native Starch Market From 2026 To 2030?

The pharmaceuticals native starch market has demonstrated robust expansion recently. This market is projected to expand from $6.11 billion in 2025 to $6.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. Historically, this growth can be attributed to factors such as the availability of natural starch sources, the increasing prevalence of generic pharmaceuticals, the extensive application of tablets and capsules, cost considerations in drug formulation, and the regulatory acceptance of native starch.

The pharmaceuticals native starch market is projected to experience substantial growth over the coming years, reaching a value of $9.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated expansion during the forecast period is driven by factors such as the rise of clean-label drug formulations, stricter sustainability mandates, the broadening of pharmaceutical manufacturing activities in developing markets, an increasing need for biodegradable excipients, and innovations in starch processing. Key developments expected during this timeframe include a heightened demand for natural and clean-label excipients, increased integration into solid oral dosage forms, growing utilization as both binders and disintegrants, the wider availability of plant-based pharmaceutical ingredients, and a greater emphasis on affordable excipients.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Drivers Are Supporting The Pharmaceuticals Native Starch Market Growth?

The increasing occurrence of chronic diseases is projected to stimulate the growth of the pharmaceuticals native starch market moving forward. Chronic diseases are enduring medical conditions that typically progress slowly and persist for a year or longer. The rising prevalence of these conditions is primarily linked to an aging population, as older individuals are more susceptible to long-term health issues such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with advancing age. Pharmaceuticals native starch offers benefits for chronic diseases by enhancing drug formulation stability, boosting bioavailability, enabling controlled drug release, supporting patient adherence, and ultimately strengthening the effectiveness and long-term management of chronic medical conditions. For instance, in April 2025, according to the Centers for Disease Control and Prevention, 76.4% of U.S. adults, representing approximately 194 million people, reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the growing prevalence of chronic diseases is a key factor driving the pharmaceuticals native starch market. The expansion of generic drug manufacturing is anticipated to propel the growth of the pharmaceuticals native starch market in the future. Generic drug manufacturing refers to the production of off-patent medications that are biologically equivalent to their branded counterparts. This rise in generic drug manufacturing is attributed to increasing regulatory support that streamlines approvals and encourages more companies to produce affordable alternatives to branded medicines. The expansion of generic drug manufacturing supports pharmaceuticals native starch by increasing the demand for reliable, cost-effective excipients that improve tablet formulation, stability, and drug delivery efficiency across a broader range of high-volume generic medicines. For example, in November 2024, the Food and Drug Administration (FDA) reported that in FY 2023, the FDA approved 782 Abbreviated New Drug Applications (ANDAs), an increase from 722 approvals recorded in FY 2022. Consequently, the expansion of generic drug manufacturing is driving the growth of the pharmaceuticals native starch market.

Which Segment Types Are Examined In The Pharmaceuticals Native Starch Market Segment Study?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch

2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Which Trends Are Guiding The Direction Of The Pharmaceuticals Native Starch Market?

Leading companies in the pharmaceuticals native starch market are concentrating on developing innovative products, such as plant-based textures, to improve drug formulation and patient compliance. Plant-based texture refers to the physical characteristics derived from plant ingredients, like thickness and gel strength, and supports pharmaceutical applications of native starch by enhancing tablet binding, disintegration, and mouthfeel for better natural drug formulations. For example, in February 2024, Ingredion Incorporated, a US-based food company, introduced Novation Indulge 2940 starch, a clean-label texturizer formulated to boost texture and stability in dairy and alternative dairy products. This novel pharmaceutical native starch delivers functional properties that enhance drug formulation performance, bioavailability, and controlled release, concurrently supporting the creation of clean-label, sustainable products. The versatile NOVATION Indulge 2940 starch is an ingredient that improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, utilizing clean-label, natural ingredients.

Which Players Are Part Of The Competitive Landscape Of The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

Get The Full Pharmaceuticals Native Starch Market Report:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

Which Region Holds The Highest Market Share In The Pharmaceuticals Native Starch Market?

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmaceuticals Native Starch Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2026, By The Business Research Company

Modified Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/modified-starch-global-market-report

Industrial Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-starch-global-market-report

Starch Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/starch-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Pharmaceuticals Native Starch Market Evolve From 2026 To 2030?

The pharmaceuticals native starch market has shown significant growth in recent years. Its size is expected to increase from $6.11 billion in 2025 to $6.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. Historically, this expansion has been driven by the accessibility of natural starch sources, the proliferation of generic pharmaceuticals, the extensive use of tablets and capsules, the focus on cost sensitivity in drug formulation, and the regulatory approval of native starch.

The pharmaceuticals native starch market size is projected to experience substantial expansion over the upcoming years, reaching $9.23 billion by 2030, with an anticipated compound annual growth rate (CAGR) of 8.6%. This projected growth can be attributed to several factors, including an increase in clean-label drug formulations, heightened sustainability demands, the growth of pharmaceutical manufacturing in developing markets, a greater need for biodegradable excipients, and advancements in starch processing. Key trends expected during this period encompass a rising demand for natural and clean-label excipients, their increased utilization in solid oral dosage forms, a growing adoption as binders and disintegrants, the expansion of plant-based pharmaceutical ingredients, and an enhanced focus on cost-effective excipients.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Pharmaceuticals Native Starch Market?

The growing occurrence of chronic illnesses is anticipated to fuel the expansion of the pharmaceuticals native starch market in the future. Chronic illnesses are persistent health conditions that typically advance slowly and endure for at least one year. This increasing prevalence of chronic diseases is primarily due to the growing elderly population, as older individuals are more prone to enduring health issues like diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with advancing age. Pharmaceuticals native starch assists in managing chronic diseases by enhancing drug formulation stability, improving bioavailability, enabling controlled drug release, supporting patient adherence, and ultimately boosting the effectiveness and long-term management of these conditions. For instance, in April 2025, the Centers for Disease Control and Prevention, a US-based federal public health agency, reported that 76.4% of U.S. adults, approximately 194 million individuals, stated they had one or more chronic conditions in 2023. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the rising incidence of chronic diseases is propelling the growth of the pharmaceuticals native starch market. The expansion of generic drug manufacturing is projected to stimulate the growth of the pharmaceuticals native starch market moving forward. Generic drug manufacturing involves the creation of medications whose patents have expired, which are biologically equivalent to their brand-name counterparts. The increase in generic drug manufacturing is driven by enhanced regulatory support, which accelerates approvals and encourages more companies to produce affordable alternatives to proprietary drugs. The growth of generic drug manufacturing benefits pharmaceuticals native starch by increasing the demand for dependable, cost-effective excipients that improve tablet formulation, stability, and drug delivery efficiency across a wider array of high-volume generic medicines. For instance, in November 2024, according to the Food and Drug Administration (FDA), a US-based federal agency, FY 2023 saw the FDA approve 782 Abbreviated New Drug Applications (ANDAs), an increase from 722 approvals recorded in FY 2022. Therefore, the expansion of generic drug manufacturing is fueling the growth of the pharmaceuticals native starch market.

Which Segment Areas Are Covered In The Pharmaceuticals Native Starch Market Analysis?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch

2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

What Key Developments And Trends Are Impacting The Pharmaceuticals Native Starch Market?

Key players within the pharmaceuticals native starch market are concentrating on creating novel offerings, particularly plant-derived textures, aimed at improving drug formulation processes and boosting patient adherence. This plant-based texture encompasses physical characteristics originating from plant components, like viscosity and gel strength. It assists the pharmaceutical industry in utilizing native starch more effectively by improving tablet cohesion, breakdown, and sensory experience for advanced natural drug formulations. As an illustration, in February 2024, Ingredion Incorporated, a food company based in the US, introduced Novation Indulge 2940 starch, which functions as a clean-label texturizer crafted to bolster texture and stability across dairy and alternative dairy product categories. This cutting-edge pharmaceutical native starch provides functional attributes that elevate drug formulation efficacy, bioavailability, and regulated release, simultaneously promoting the creation of clean-label and environmentally friendly products. Furthermore, NOVATION Indulge 2940 starch serves as a adaptable component, enhancing texture, stability, and consumer appeal in both traditional dairy and plant-based dairy alternatives, by leveraging clean-label, natural constituents.

Which Global Companies Are Actively Competing In The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

Read the full pharmaceuticals native starch market report here:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Are The Leading Geographic Regions In The Pharmaceuticals Native Starch Market?

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pharmaceuticals Native Starch Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2026, By The Business Research Company

Modified Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/modified-starch-global-market-report

Industrial Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-starch-global-market-report

Starch Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/starch-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceuticals native starch market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Pharmaceuticals Native Starch Market covering 2026–2035?

The pharmaceuticals native starch market size has experienced strong growth in recent years. It is projected to expand from $6.11 billion in 2025 to $6.64 billion in 2026, at a compound annual growth rate (CAGR) of 8.6%. The historical growth can be attributed to factors such as the availability of natural starch sources, the expansion of generic pharmaceuticals, the widespread adoption of tablets and capsules, cost sensitivity in drug formulation, and regulatory acceptance of native starch.

The pharmaceuticals native starch market is poised for significant expansion in the foreseeable future. Its valuation is forecast to reach $9.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated growth is driven by various factors such as the rise of clean-label drug formulations, escalating sustainability demands, the growth of pharmaceutical manufacturing in emerging markets, an increasing need for biodegradable excipients, and advancements in starch processing. Key trends projected for this period include an expanding preference for natural and clean-label excipients, their broader application in solid oral dosage forms, increased usage as binders and disintegrants, the growth of plant-based pharmaceutical ingredients, and a greater focus on developing cost-effective excipients.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Pharmaceuticals Native Starch Market?

The growing incidence of chronic health conditions is anticipated to boost the expansion of the pharmaceuticals native starch market moving forward. Chronic diseases are defined as long-term medical ailments that typically progress slowly and persist for a year or longer. This increasing prevalence is primarily linked to the rising aging population, as elderly individuals are more susceptible to enduring health issues such as diabetes, cardiovascular diseases, arthritis, and cancer, which commonly become more widespread with age. Pharmaceuticals native starch contributes to the management of chronic diseases by enhancing drug formulation stability, improving drug bioavailability, enabling controlled drug release, supporting patient adherence, and ultimately strengthening the effectiveness and long-term care of these medical conditions. For instance, in April 2025, data from the Centers for Disease Control and Prevention, a US-based federal public health agency, revealed that 76.4% of U.S. adults, representing approximately 194 million people, reported having one or more chronic conditions in 2023, with the prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the increasing prevalence of chronic diseases is a key factor driving the growth of the pharmaceuticals native starch market.

What Segments Are Identified Within The Structure Of The Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch

2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

How Are Emerging Trends Affecting The Progression Of The Pharmaceuticals Native Starch Market?

Major companies in the pharmaceuticals native starch market are prioritizing the creation of innovative products, such as plant-based textures, to enhance drug formulation and improve patient compliance. Plant-based texture refers to the physical characteristics derived from plant ingredients, including thickness and gel strength, which assists pharmaceuticals in using native starch by improving tablet binding, disintegration, and mouthfeel for better natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, introduced Novation Indulge 2940 starch, a clean-label texturizer designed to enhance texture and stability in dairy and alternative dairy products. This advanced pharmaceutical native starch offers functional properties that elevate drug formulation performance, bioavailability, and controlled release, while also supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch is a versatile ingredient that improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, utilizing clean-label, natural ingredients.

Which Major Firms Are Strengthening Their Position In The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Pharmaceuticals Native Starch Market?

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmaceuticals Native Starch Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2026, By The Business Research Company

Modified Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/modified-starch-global-market-report

Industrial Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-starch-global-market-report

Starch Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/starch-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceuticals native starch market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Pharmaceuticals Native Starch Market Size Today And What Will Its Value Be At The End Of 2029?

The pharmaceuticals native starch market size has experienced significant expansion over recent years. It is anticipated to grow from $5.65 billion in 2024 to $6.11 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.1%. The historical increase can be attributed to several factors, including an elevated demand for natural excipients, increasing pharmaceutical output, a growing inclination towards biocompatible ingredients, the broadening of generic drug manufacturing, and rising regulatory endorsement for natural ingredients.

The pharmaceuticals native starch market is projected to experience substantial expansion over the next few years, with its size anticipated to reach $8.5 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.6%. This projected growth during the forecast period stems from factors such as increasing investment in pharmaceutical innovation, a heightened emphasis on sustainable sourcing, the broadening of applications in novel drug formulations, a rising demand for clean-label pharmaceutical products, and increasing healthcare expenditure in emerging markets. Furthermore, significant trends foreseen in this period include technological advancements in starch processing, innovations in drug delivery systems, the development of bio-based pharmaceutical ingredients, intensified research and development concerning plant-based excipients, and the creation of solubility and stability solutions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Key Drivers Are Powering Growth In The Pharmaceuticals Native Starch Market?

The escalating occurrence of chronic illnesses is anticipated to fuel the expansion of the pharmaceuticals native starch market. Chronic diseases are defined as prolonged medical conditions that typically advance gradually and persist for at least a year. This rise in chronic disease prevalence is primarily due to an aging global population, as older individuals are more susceptible to long-term health issues such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with advancing age. Pharmaceuticals native starch proves beneficial in the context of chronic diseases by improving drug formulation stability, enhancing drug absorption, facilitating controlled drug release, supporting patient compliance, and ultimately bolstering the effectiveness and sustained management of these medical conditions. As an illustration, in June 2024, data from the Australian Institute of Health and Welfare indicated an increase in the death rate from chronic conditions, rising from 459 per 100,000 people in 2021 to 490 per 100,000 people in 2022. Therefore, the growing burden of chronic diseases is a significant driver for the growth of the pharmaceuticals native starch market.

Which Segment Categories Are Driving Maximum Growth In The Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Modified Potato Starch, Native Potato Starch

2) By Corn Starch: Modified Corn Starch, Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

What Key Trends Are Driving Growth In The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are concentrating on developing innovative products, such as plant-based textures, to optimize drug formulation and improve patient compliance. Plant-derived texture refers to physical properties derived from botanical ingredients, including thickness and gel strength, aiding pharmaceuticals in using native starch by enhancing tablet binding, disintegration, and mouthfeel for improved natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to enhance texture and stability in dairy and alternative dairy products. This novel pharmaceutical native starch offers functional properties that improve drug formulation performance, bioavailability, and controlled release, while also supporting the development of clean-label, sustainable products. Furthermore, NOVATION Indulge 2940 starch is a versatile ingredient that enhances texture, stability, and consumer acceptance in both dairy and alternative dairy products, by using clean-label, natural ingredients.

Who Are The Leading Companies Driving The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Frères SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Shandong Liujia Pharmaceutical Excipient Co.Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

Which Region Holds The Largest Share In The Pharmaceuticals Native Starch Market Today?

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2025, By The Business Research Company

Generic Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Pharmaceuticals Market 2025

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Radiopharmaceutical Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market size has experienced significant expansion over recent years. It is anticipated to increase from $5.65 billion in 2024 to $6.11 billion in 2025, driven by a compound annual growth rate (CAGR) of 8.1%. This growth during the past period is primarily due to the heightened demand for natural excipients, increasing pharmaceutical output, a growing preference for biocompatible ingredients, the expansion of generic drug manufacturing, and rising regulatory encouragement for natural ingredients.

The pharmaceuticals native starch market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $8.5 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 8.6%. Key factors driving this growth during the forecast period include increasing investment in pharmaceutical innovation, an amplified focus on sustainable sourcing, expanding applications within novel drug formulations, a heightened demand for clean-label pharmaceutical products, and growing healthcare expenditure in emerging markets. Significant trends observed during this period encompass technological advancements in starch processing, innovations within drug delivery systems, new developments in bio-based pharmaceutical ingredients, extensive research and development in plant-based excipients, and the creation of solubility and stability solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Pharmaceuticals Native Starch Industry?

The rising incidence of chronic ailments is anticipated to drive expansion in the pharmaceuticals native starch market moving ahead. These conditions are enduring health issues, generally characterized by a gradual progression and a duration of at least one year. The heightened occurrence of chronic diseases stems largely from the growing elderly demographic, given that older people are more prone to prolonged health problems like diabetes, cardiovascular diseases, arthritis, and cancer, which typically become more widespread as people age. Pharmaceuticals native starch proves beneficial in the context of chronic diseases by enhancing drug formulation stability, boosting bioavailability, facilitating regulated drug release, aiding patient adherence, and ultimately reinforcing the efficacy and sustained management of these medical conditions. As an illustration, data from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based government agency, indicated an increase in the mortality rate from chronic conditions, moving from 459 per 100,000 people in 2021 to 490 per 100,000 people in 2022. Consequently, the rising occurrence of chronic illnesses is propelling the expansion of the pharmaceuticals native starch market.

What Are The Key Segments In The Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Modified Potato Starch, Native Potato Starch

2) By Corn Starch: Modified Corn Starch, Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Which Ongoing Trends Are Expected To Shape The Pharmaceuticals Native Starch Market Outlook?

Leading companies in the pharmaceuticals native starch market are concentrating on developing innovative products, such as plant-based textures, to enhance drug formulation and improve patient compliance. Plant-based texture refers to the physical characteristics derived from botanical ingredients, including thickness and gel strength, and assists pharmaceuticals in using native starch by improving tablet binding, disintegration, and mouthfeel for better natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to improve texture and stability in dairy and alternative dairy products. This advanced pharmaceutical native starch offers functional properties that boost drug formulation performance, bioavailability, and controlled release, while also supporting the creation of clean-label, sustainable products. NOVATION Indulge 2940 starch is a versatile ingredient that enhances texture, stability, and consumer acceptance in both dairy and alternative dairy products, utilizing clean-label, natural ingredients.

Who Are The Major Companies Operating In The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Frères SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Shandong Liujia Pharmaceutical Excipient Co.Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Are The Key Regional Factors Influencing The Pharmaceuticals Native Starch Market Growth?

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharmaceuticals Native Starch Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2025, By The Business Research Company

Generic Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Pharmaceuticals Market 2025

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Radiopharmaceutical Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Pharmaceuticals Native Starch Market Size from 2025 to 2034?

The size of the pharmaceuticals native starch market has seen significant growth recently. The market is projected to expand from $5.65 billion in 2024 to $6.11 billion in 2025, at a compound annual growth rate (CAGR) of 8.1%. This substantial growth during the historic period is driven by several factors, which includes a higher demand for natural excipients, increased levels of pharmaceutical production, a growing preference for biocompatible ingredients, an upsurge in generic drug manufacturing, and increased regulatory support for natural components.

In the upcoming years, the market size of native starch in the pharmaceutical industry is predicted to experience substantial growth. It is projected to escalate to $8.5 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. The prospering growth during the forecasted period is linked to several factors including the upsurge in pharmaceutical innovation investments, growing emphasis on sustainable sourcing, increasing applications of innovative drug formulations, a surge in the demand for clean-label pharmaceutical products, and elevated healthcare spending in developing markets. Key trends expected to dominate the forecast period involve advancements in technology for starch processing, innovative strides in drug delivery systems, progression in bio-based pharmaceutical elements, research, and innovation in plant-derived excipients, and ways to enhance solubility and stability.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePharmaceuticals Native Starch Market?

The surge in chronic disease occurrence is predicted to spur the expansion of the pharmaceuticals native starch market. Chronic diseases are enduring medical conditions that usually progress gradually and last for a year or more. The surge in chronic diseases is primarily linked to the increasing aging population, with older individuals more prone to enduring health conditions like diabetes, cardiovascular diseases, arthritis, and cancer, which tend to become more prevalent with age. Pharmaceuticals native starch aids in managing chronic diseases by promoting stability in drug formulations, enhancing bioavailability, facilitating controlled drug release, encouraging patient compliance, and ultimately boosting the efficacy and long-term management of chronic health conditions. For example, as per the data from the Australian Institute of Health and Welfare, an Australian government agency, in June 2024, the mortality rate due to chronic conditions observed an increase, soaring from 459 per 100,000 individuals in 2021 to 490 per 100,000 individuals in 2022. Therefore, the ascending prevalence of chronic diseases is propelling the growth of the pharmaceuticals native starch market.

Which Segments in the Pharmaceuticals Native Starch Offer the Most Growth?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Modified Potato Starch, Native Potato Starch

2) By Corn Starch: Modified Corn Starch, Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePharmaceuticals Native Starch Market?# Market?

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Pharmaceuticals Native Starch Industry?

Leading pharmaceutical companies in the native starch market are working on creating innovative products such as plant-based textures, intended to elevate drug formulation and foster increased patient conformity. Plant-based textures, derived from the physical properties of plant components like thickness and gel strength, aid the utilization of native starch in pharmaceuticals by elevating the tablet binding, disintegration, and mouthfeel for better natural drug formulations. For example, the US-based food company Ingredion Incorporated introduced Novation Indulge 2940 starch in February 2024, an innovative pharmaceutical native starch that provides functional benefits like enhancing drug formulation efficiency, bioavailability, and controlled remission, alongside contributing to the creation of sustainable, clean-label products. The Novation Indulge 2940 starch is a multi-functional ingredient that enriches texture, stability, and consumer approval in both dairy and dairy-alternative products, through the use of natural, clean-label ingredients.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Are the Key Elements That Define the Pharmaceuticals Native Starch Market?

Pharmaceutical native starch is unaltered starch derived from natural sources such as corn, potato, wheat, or tapioca and utilized as an excipient in pharmaceutical formulations. It functions as a binder, disintegrant, or filler in tablets and capsules, helping to control medication release, increase stability, and maintain appropriate tablet formation without requiring chemical or physical change.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24376

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

How Has The Pharmaceuticals Native Starch Market Size Shifted, And What Is the Outlook Through 2034?

The growth of the pharmaceutical native starch market has been robust over recent years. The market which stood at $5.65 billion in 2024 is projected to escalate to $6.17 billion by 2025, delivering a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this significant growth in the past include a heightened demand for natural excipients, a surge in pharmaceutical manufacturing, an increased inclination towards biocompatible ingredients, an expansion of generic drug manufacturing, and increased regulatory backing for natural constituents.

Expectations for the pharmaceutical native starch market size predict robust expansion in the years to come, rising to the value of $8.69 billion in 2029 with a compound annual growth rate (CAGR) of 8.9%. This projected growth during the forecast period can be attributed to factors such as increased investments in pharmaceutical innovation, a growing emphasis on sustainable sourcing, extended applications in innovative drug formulations, a rise in demand for pharmaceutical products with clean labels, and increased healthcare expenditures in developing markets. Future trends projected during this period are technological advancements in starch processing, innovations in systems for drug delivery, progress in bio-based pharmaceutical ingredients, as well as research and development in plant-based excipients, and development of solubility and stability solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Pharmaceuticals Native Starch Market?

The escalating occurrence of chronic illnesses is anticipated to spur the expansion of the pharmaceuticals native starch market. Chronic illnesses are enduring health issues that usually progress at a slow pace and last for over a year. The surge in chronic illnesses is mainly due to the increasing elderly population who are more prone to persistent ailments such as diabetes, cardiovascular diseases, arthritis, and cancer; these health issues commonly increase with age. The pharmaceuticals native starch aids in chronic disease management by boosting drug formulation stability, improving bioavailability, providing controlled drug release, assisting patient adherence, and ultimately reinforcing the effectiveness and long-term control of chronic health conditions. For instance, in June 2024, the Australian Institute of Health and Welfare, a government organization in Australia, reported a rise in the mortality rate due to chronic conditions, surging from 459 per 100,000 individuals in 2021 to 490 per 100,000 individuals in 2022. Hence, the escalating occurrence of chronic diseases is fueling the growth of the pharmaceuticals native starch market.

What Segment Types Define the Pharmaceuticals Native Starch Market Structure?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Modified Potato Starch, Native Potato Starch

2) By Corn Starch: Modified Corn Starch, Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Pharmaceuticals Native Starch Market?

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Pharmaceuticals Native Starch Market?

Leading businesses in the native starch market for pharmaceuticals are prioritizing the creation of innovative plant-based textured products to optimize medication formulation and increase patient adherence. Plant-based texture, derived from plant ingredients like thickness and gel strength, aids pharmaceutical companies in utilizing native starch to improve tablet binding, disintegration, and mouthfeel for more natural drug formulations. For example, Ingredion Incorporated, a food company based in the US, introduced Novation Indulge 2940 starch in February 2024 — a clean-label texturizer targeted at improving texture and stability in dairy and non-dairy products. This novel native starch for pharmaceutical use offers functional characteristics that boost medication formulation effectiveness, bioavailability, and timed release while promoting the creation of clean-label, eco-friendly products. NOVATION Indulge 2940 starch is a flexible ingredient that enhances texture, stability, and consumer approval in dairy and non-dairy products, utilizing clean-label, natural constituents.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Is the Definition of the Pharmaceuticals Native Starch Market?

Pharmaceutical native starch is unaltered starch derived from natural sources such as corn, potato, wheat, or tapioca and utilized as an excipient in pharmaceutical formulations. It functions as a binder, disintegrant, or filler in tablets and capsules, helping to control medication release, increase stability, and maintain appropriate tablet formation without requiring chemical or physical change.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model